(Q43277428)

18 November 2017

title

Diffuse white matter damage is absent in neuromyelitis optica (English)

1 reference

18 November 2017

F Aboul-Enein

1

1 reference

18 November 2017

M Krssák

2

1 reference

18 November 2017

R Höftberger

3

1 reference

18 November 2017

D Prayer

4

1 reference

18 November 2017

W Kristoferitsch

5

1 reference

18 November 2017

publication date

12 September 2009

1 reference

American Journal of Neuroradiology

18 November 2017

published in

1 reference

18 November 2017

volume

31

1 reference

18 November 2017

issue

1

1 reference

18 November 2017

page(s)

76-79

1 reference

The spectrum of neuromyelitis optica

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Differential diagnosis of suspected multiple sclerosis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

1 H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

NMR relaxation times in the human brain at 3.0 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

White matter spectroscopy in neuromyelitis optica: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

OSMS is NMO, but not MS: proven clinically and pathologically

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A1791

21 January 2018

Identifiers

DOI

10.3174/AJNR.A1791

1 reference

18 November 2017

1 reference